Business
Goldman’s new gold target: Why the Wall Street bank is saying it’s early to buy the yellow metal
By Katherine Langford
Moderna’s stock jumps after biotech raises sales outlook
Katherine Langford
Katherine Langford
Editor-in-Chief · Edina, MN
Katherine oversees editorial operations across all six brands. Before joining The Meridan Group, she spent 14 years at the Minneapolis Star Tribune, where she led the metro desk through its digital transformation. She holds a Master's in Journalism from Northwestern's Medill School.
More from Katherine →Editor-in-Chief · Friday, November 6, 2026 at 12:48 PM · 1 min read
The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
Up nextGoldman’s new gold target: Why the Wall Street bank is saying it’s early to buy the yellow metalBusiness · 1 min read
More Business stories
Business
The S&P 500’s most reliable dividend stocks are beating the market. Here’s how to play them.
By Katherine Langford
Business
‘I have no financial safety net’: I’m 66, rely on Social Security and have just $500 in savings. What hope do I have?
By Katherine Langford
Business
Chip stocks are the cheapest they’ve been in nearly seven years. How low is too low?
By Katherine Langford